Approval · Notice of Compliance 17538 · 2015
REVLIMID: Notice of Compliance 17538
Issued October 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17538
- Date
- October 16, 2015
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVLIMID | Not yet assigned | — |
Medicinal ingredients
- LENALIDOMIDE 5 MG per CAP
- LENALIDOMIDE 10 MG per CAP
- LENALIDOMIDE 15 MG per CAP
- LENALIDOMIDE 20 MG per CAP
- LENALIDOMIDE 25 MG per CAP